Liquid cannabinoid formulations
US8222292B2 · kind B2 · utility
53Cited by
4References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 31, 2011 |
| Grant date | Jul 17, 2012 |
| Priority date | — |
| Expiry date | Aug 31, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Oral cannabinoid formulations, including an aqueous-based oral dronabinol solution, that are stable at room or refrigerated temperatures and may possess improved in vivo absorption profiles with faster onset and lower inter-subject variability.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.